Paclitaxel- and sirolimus-eluting stents in older patients with diabetes mellitus: Results of a real-life multicenter registry

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 7, 2013, Pages 1117-1124

  Buja, Paolo ^a   Facchin, Michela ^a   Musumeci, Giuseppe ^b   Frigo, Anna Chiara ^a   Saia, Francesco ^c   Menozzi, Alberto ^d   Meliga, Emanuele ^e   Sardella, Gennaro ^f   Tamburino, Corrado ^g   Tarantini, Giuseppe ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e MAURIZIANO HOSPITAL   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY OF CATANIA   (Italy)

Author keywords

diabetes; drug eluting stent; paclitaxel eluting stent; sirolimus eluting stent

Indexed keywords

INSULIN; PACLITAXEL; RAPAMYCIN;

AGE DISTRIBUTION; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; REVASCULARIZATION; SIROLIMUS ELUTING STENT; TARGET LESION REVASCULARIZATION; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878253347     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24636     Document Type: Article

References (29)

1. Goulding MR, Rogers ME,. Centers for disease control and prevention: Trends in aging-United States and worldwide. MMWR Morb Mortal Wkly Rep 2003; 52: 101-104,106.
2. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. National Institutes of Health. National Heart, Lung, and Blood Institute, 2006.
3. Badran HM, Elnoamany MF, Khalil TS, Ezz Eldin MM,. Age-related alteration of risk profile, inflammatory response, and angiographic findings in patients with acute coronary syndrome. Clin Med Cardiol 2009; 3: 15-28.
4. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD,. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: The third national health and nutrition examination survey, 1988-1994. Diabetes Care 1998; 21: 518-524.
5. Ryan J, Linde-Zwirble W, Engelhart L, Cooper L, Cohen DJ,. Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: Results from the US Medicare program. Circulation 2009; 119: 952-961.
6. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM,; American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology. Acute coronary care in the elderly, Part1: Non-ST-segment-elevation cute coronary syndromes: A scientific statement for healthcare professions from the American heart association council on clinical cardiology: In collaboration with the society of geriatric cardiology. Circulation 2007; 115: 2549-2569.
7. Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, Haque G, Dai D, Kong DF, Hammill B, Curtis L, Matchar D, Brindis R, Peterson ED,. Clinical effectiveness of coronary stents in the Elderly: Results from 262,700 medicare patients in ACC-NCDR. J Am Coll Cardiol 2009; 53: 1629-1641.
8. McKellar SH, Brown ML, Frye RL, Schaff HV, Sundt TM III,. Comparison of coronary revascularization procedures in octogenarians: A systematic review and meta-analysis. Nat Clin Pract Cardiovasc Med 2008; 5: 738-746.
9. Groeneveld PW, Matta MA, Greenhut AP, Yang F,. Drug-eluting compared with bare-metal coronary stents among elderly patients. J Am Coll Cardiol 2008; 51: 2017-2024.
10. Costa JR Jr, Sousa A, Moreira AC, Costa RA, Maldonado G, Cano MN, Egito ET, Romano ER, Barbosa M, Pavanello R, Jardim C, Cury A, Berwanger O, Sousa JE,. Drug-eluting stents in the elderly: Long-term (> one year) clinical outcomes of octogenarians in the DESIRE (drug eluting stents in the real world) registry. J Invasive Cardiol 2008; 20: 404-410.
11. Tarantini G, Facchin M, Capodanno D, Musumeci G, Saia F, Menozzi A, Meliga E, Mancone M, Lettieri C, Tamburino C,. Paclitaxel versus sirolimus eluting stents in diabetic patients: Does stent type and/or stent diameter matter? Long-term clinical outcome of 2429-patient multicenter registry. Catheter Cardiovasc Interv 2012. doi: 10.1002/ccd.24445.
12. American Diabetes Association. Standards of medical care in Diabetes 2009. Diabetes Care 2009; 32: S13-S61.
13. Austin PC, Grootendorst P, Anderson GM,. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: A Monte Carlo study. Stat Med 2007; 26: 734-753.
14. Chiu M, Ko DT, Austin PC, Cohen EA, Velianou JL, Goeree R, Blackhouse G, Tu JV,. Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients. Circ Cardiovasc Qual Outcomes 2009; 2: 96-107.
15. Klein JP, Moeschberger ML,. Survival Analysis: Techniques for Censored and Truncated Data. New York: Springer-Verlag; 1997.
16. Mulukutla SR, Vlachos HA, Marroquin OC, Selzer F, Holper EM, Abbott JD, Laskey WK, Williams DO, Smith C, Anderson WD, Lee JS, Srinvas V, Kelsey SF, Kip KE,. Impact of drug-eluting stents among insulin-treated diabetic patients: A report from the National heart, lung, and blood institute dynamic registry. JACC Cardiovasc Interv 2008; 1: 139-147.
17. Stettler C, Allemann S, Wandel S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, De Carlo M, Erglis A, Chechi T, Ortolani P, Schalij MJ, Diem P, Meier B, Windecker S, Jüni P,. Drug eluting and bare metal stents in people with and without diabetes: Collaborative network meta-analysis. Br Med J 2008; 337: a1359.
18. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schömig A,; ISAR-DIABETES study investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005; 353: 663-670.
19. Sanfilippo A, Cumbo M, Caggegi AM, Monaco S, Bucalo R, Ruperto C, Tamburino C, Ussia GP, Galassi AR, Capranzano P, Capodanno D, Tamburino C,. Long term outcomes comparison of different type of DES in elderly patients from a real-world experience. J Invasive Cardiol 2009; 21: 330-333.
20. Buja P, Lanzellotti D, Isabella G, Napodano M, Panfili M, Favaretto E, Iliceto S, Tarantini G,. Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: Results from a single-center allcomers registry. Heart Vessels 2011; 12: 194-195.
21. Forman DE, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, Turco MA, Wei JY, Joshi AA, Dawkins KD, Baim DS,. Long-term paclitaxel-eluting stent outcomes in elderly patients. Circ Cardiovasc Interv 2009; 2: 178-187.
22. Varani E, Aquilina M, Balducelli M, Vecchi G, Frassineti V, Maresta A,. Percutaneous coronary interventions in octogenarians: Acute and 12 month results in a large single-centre experience. Catheter Cardiovasc Interv 2009; 73: 449-454.
23. Kengne AP, Turnbull F, Macmahon S,. The Framingham study, diabetes mellitus and cardiovascular disease: Turning back the clock. Progr Cardiovasc Dis 2010; 53: 45-51.
24. Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Hong MK, Rhee KS, Chae JK, Ko JK, Park JH, Lee JH, Choi SW, Jeong JO, Seong IW, Cho YH, Lee NH, Kim JH,. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus. J Am Coll Cardiol 2008; 52: 727-733.
25. Kim JS, Lee BH, Ko YG, Choi D, Jang Y, Min PK, Yoon YW, Hong BK, Kwon HM, Ahn MS, Lee SH, Yoon JH, Lee BK, Kim BO, Kim BK, Oh SJ, Jeon DW, Yang JY, Cho JR, Jung JH, Ryu SK,; Korean Multicenter Angioplasty Team (KOMATE) Investigators. Comparison of sirolimus-eluting stent and paclitaxel- eluting stent for long-term cardiac adverse events in diabetic patients: The Korean multicenter angioplasty team (KOMATE) registry. Catheter Cardiovasc Interv 2008; 72: 601-607.
26. Wolf WM, Vlachos HA, Marroquin OC, Lee JS, Smith C, Anderson WD, Schindler JT, Holper EM, Abbott JD, Williams DO, Laskey WK, Kip KE, Kelsey SF, Mulukutla SR,. Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: A report from the national heart, lung, and blood institute dynamic registry. Circ Cardiovasc Interv. 2010; 3: 42-49.
27. Finn AV, Nakazawa G, Kolodgie FD, Virmani R,. Temporal course of neointimal formation after drug-eluting stent placement: Is our understanding of restenosis changing. J Am Coll Cardiol Interv 2009; 2: 300-302.
28. Onuma Y, Wykrzykowska JJ, Garg S, Vranckx P, Serruys PW,; ARTS I and II investigators. 5-years follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease. Insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials. J Am Coll Cardiol Interv 2011; 4: 317-323.
29. Ko YG, Kim JS, Choi D, Hong MK, Min PK, Yoon YW, Hong BK, Lee BK, Kwon HM, Kim BK, Oh SJ, Jeon DW, Yang JY, Jang Y,. Five-year outcomes of sirolimus-eluting versus paclitaxel-eluting stents: A propensity matched study: Clinical evidence of late catch-up? Int J Cardiol 2011;152:302 - 306.